ASMB · Assembly Biosciences, Inc.
$34.38
+0.85 (+2.54%)
At close · Aug 21
Market Cap
$682.69M
Shares
20.36M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$34.38
Open$33.86
Day$33.86–35.62
52W close$20.55–38.50
Avg vol 30d207K
Short int2.3M · 11.5% float · 15.8d
Short vol33%
Last earningsApr 17, 2026
DataFeb 2024–Aug 2026
Filing10-Q · Aug 13
Raw chart and full-history price indicators begin at the captured split on Feb 12, 2024; bars on opposite sides are not compared.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 13, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.1 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+18%
above
Price vs 50-day avg
+27%
above
RSI (14)
70
neutral
MACD trend
Positive
52-week position
77%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+35%
trailing
6-month return
+16%
trailing
YTD return
+1%
this year
Relative strength
+4%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $27 › 200d $29 — 200d above 50d
Institutional flow
Accumulating
+24% holders QoQ · +33 funds added
Insider flow
Distributing
Net -$674 over 90 days · 100% sells
Short interest
Rising
11.47% of float · ▲ +1.0% MoM · 15.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
93 holders — near 3-yr high, broad support
Squeeze score
80
high risk · 0–100
Fundamentals
Revenue growth
+154%
Y/Y
EPS growth
+92%
Y/Y
Free cash flow
$-41.2M
Balance sheet
$58.0M
net cash
Quant / Vol
risk profile
Volatility
59%
annualized · 1-yr
Max drawdown
−42%
past year
ATR
5.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+18%
Bullish
Price vs 50-day avg
+27%
Bullish
RSI (14)
70
Neutral
MACD trend
Positive
Bullish
52-week position
77%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $27 › 200d $29 — 200d above 50d
Institutional flow
Accumulating
+24% holders QoQ · +33 funds added
Insider flow
Distributing
Net -$674 over 90 days · 100% sells
Short interest
Rising
11.47% of float · ▲ +1.0% MoM · 15.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
93 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $21
Now $34 · 77%
Range high $39
vs 200-day avg +18%
vs 50-day avg +27%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ASMB
this stock
Assembly Biosciences, Inc.
|
$682.69M | +1.1% | +153.5% | — | 11.5% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +20.9% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.87B | +8.1% | +20.8% | 20.7 | 3.3% |
|
ARGX
Argenx SE
|
$64.56B | +23.6% | — | — | 2.1% |
|
CSLLY
Csl Ltd
|
$58.31B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
Raw-price comparisons begin at the captured split on Feb 12, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ASMB | +4.3% | +34.6% | +15.8% | +36.9% | +1.1% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | +5.7% | +30.9% | +4.3% | +34.4% | -11.2% |
Key facts
CIK
1426800
CUSIP
045396207
13F (30d)
96 filings
94 filers
Visit website
Investor relations